DBIA
CELG

Dumont & Blake Investment Advisors’s Celgene Corp CELG Stock Holding History

Dumont & Blake Investment Advisors’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-3,802
Closed -$327K – 165
2014
Q2 		$327K Hold
3,802
– – 0.16% 132
2014
Q1 		$265K Hold
3,802
– – 0.14% 130
2013
Q4 		$321K Buy
+3,802
New +$301K 0.17% 127

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Dumont & Blake Investment Advisors's CELG Position: Q3 2014 in Review

Dumont & Blake Investment Advisors sold out of Celgene Corp (CELG) in Q3 2014, closing a stake of 3,802 shares — an estimated $327K sold.

Dumont & Blake Investment Advisors first reported a position in CELG in Q4 2013 and held it in 3 quarters. The position peaked at $327K in Q2 2014. 1,031 funds tracked by Wall St. Rank hold CELG as of Q3 2014.

  • Dumont & Blake Investment Advisors reported no remaining Celgene Corp position as of Q3 2014 after selling out during the quarter.
  • Dumont & Blake Investment Advisors sold 3,802 Celgene Corp shares in Q3 2014, an estimated $327K.
  • Dumont & Blake Investment Advisors first reported a position in Celgene Corp in Q4 2013 and held it in 3 quarters.
  • Dumont & Blake Investment Advisors's Celgene Corp position peaked at $327K in Q2 2014.
  • 1,031 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2014.

Based on Dumont & Blake Investment Advisors's 13F filing for Q3 2014, filed 28 Oct 2014.